What if menopause didn’t have to happen so soon? That’s the question researchers at Columbia University are exploring with a new clinical trial testing rapamycin — an anti-aging drug that could help delay menopause by protecting ovarian function.
The study, known as the VIBRANT trial, is recruiting healthy women aged 35–45 to test whether low-dose rapamycin can slow down ovarian aging. Early research in animals showed impressive results: extended fertility and preserved hormone levels for years longer.
This marks one of the most promising new treatments to delay menopause in 2025 — not just to extend fertility, but to potentially postpone symptoms like hot flashes, brain fog, and bone loss.
🧪 If successful, this therapy could give women more time, more options, and more control over how they age.
💬 Note: This article is for informational purposes only and is not medical advice. Always talk to your healthcare provider before starting or changing any treatment.
👉 Follow us for updates on this and other menopause breakthroughs.